feed,title,long_url,short_url
Benzinga,"Ultragenyx's Neurogenetic Disorder Candidate Shows Favorable Tolerability, Clinical Activity",https://benzinga.com/general/biotech/22/07/28110255/ultragenyxs-neurogenetic-disorder-candidate-shows-favorable-tolerability-clinical-activity,https://bit.ly/3Onuxnr
